Efficacy, safety of anakinra plus standard of care for patients with severe COVID-19

JAMA Network Open

2023-04-07

(Press-News.org) About The Study: In this randomized clinical trial, anakinra did not prevent the need for mechanical ventilation or reduce mortality risk compared with standard of care alone among hospitalized patients with severe COVID-19 pneumonia. Future research should assess anakinra in patients with less severe pneumonia.

Authors: Patricia Fanlo, M.D., Ph.D., of the Hospital Universitario de Navarra in Pamplona, Spain, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2023.7243)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.7243?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040723

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

Severe maternal morbidity, mortality of pregnant patients with COVID-19 infection during early pandemic period

2023-04-07

About The Study: This national-level analysis found substantial adverse maternal outcomes among pregnant patients with COVID-19 infection at delivery during the early pandemic in the U.S. Specifically, the odds of severe respiratory complications were increased among pregnant patients with COVID-19 infection at delivery. Authors: Koji Matsuo, M.D., Ph.D., of the University of Southern California in Los Angeles, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2023.7149) Editor’s ...

Researchers find comprehensive sex education reduces homophobia, transphobia

2023-04-07

Can a school-based sexual health education program that effectively reduces the risk of unintended pregnancy and STIs also decrease homophobia and transphobia? That question drove a collaborative effort by researchers conducting a randomized controlled trial of an inclusive comprehensive sex education program – High School FLASH. The study evaluated not just the impact on students’ sexual behaviors and related outcomes but also on their homophobic and transphobic beliefs (Coyle et al., 2021). With funding from the U.S. Department of Health and Human Services, researchers evaluated High School FLASH in 20 schools in two U.S. regions (Midwest and South). ...

Terna and Istituto Italiano di Tecnologia together for innovation and research

2023-04-07

Rome (Italy), 7th April 2023 - Terna, the company led by Stefano Donnarumma that manages the national transmission grid, and Istituto Italiano di Tecnologia (IIT- Italian Institute of Technology) have signed a five-year collaboration agreement aimed at studying and implementing innovative solutions in the field of robotics to support the company's field activities. The agreement was signed on April 6th in Rome by Massimiliano Garri, Terna's Head of Innovation & Market Solutions, and Giorgio Metta, IIT Scientific Director. "We are proud to start the collaboration with an excellence on the Italian ...

Two-organ chip to answer fatty liver questions

2023-04-07

A new chip that holds different cell types in tiny, interconnected chambers could allow scientists to better understand the physiological and disease interactions between organs. The integrated-gut-liver-on-a-chip (iGLC) platform was designed by scientists at Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS), to improve understanding of non-alcoholic fatty liver disease (NAFLD). The researchers, together with colleagues in Japan, published their findings in the journal Communications ...

Retinal microvasculature is a potential biomarker for acute mountain sickness

2023-04-07

This study is led by Dr.Ningli Wang and Dr.Yuan Xie (Beijing Tongren Hospital, Capital Medical University), they provide evidence that retinal microvasculature is a potential biomarker for cerebral microvasculature changes and acute mountain sickness(AMS) development during risk assessment of individuals at high altitudes. Since the retinal and cerebral vasculature share many morphological and physiological characteristics, direct evaluation of the more accessible retinal vasculature should theoretically provide insights into the cerebral circulation. Therefore, the role of retinal imaging ...

Researchers leverage cell self-destruction to treat brain tumors

2023-04-07

CHAPEL HILL, N.C. – Glioblastoma is the most common type of brain tumor in adults. The disease is 100% fatal and there are no cures, making it the most aggressive type of cancer. Such a poor prognosis has motivated researchers and neurosurgeons to understand the biology of tumors with the goal of creating better therapies. Dominique Higgins, MD, PhD, an assistant professor in the Department of Neurosurgery, has heeded the call. Higgins and a team of researchers at Columbia University have found ...

Deaths by suicide increase significantly during the week of a full moon

2023-04-07

INDIANAPOLIS—For centuries, people have suspected a full moon in the sky to cause mysterious changes in people. Now, psychiatrists at Indiana University School of Medicine have found deaths by suicide increase during the full moon. “We wanted to analyze the hypothesis that suicides are increased during the period around full moons and determine if high-risk patients should be followed more closely during those times,” said Alexander Niculescu, MD, PhD. Niculescu and his team looked at data from the Marion County coroner’s ...

How to make electronic noses smell better

2023-04-07

Imagine if you could ask a machine to “smell” something for you with just a click of a button. That’s what electronic noses, or e-noses, are for. They are systems that combine chemical gas sensors, signal processing and machine learning algorithms to mimic the sense of smell. E-noses can be used for many purposes, such as checking food quality, monitoring air pollution, diagnosing diseases and detecting explosives. How do they work? What are the challenges and opportunities in this field? A team led by Jingdong Chen of Northwestern Polytechnical University in Xi’an, China and ...

Study assesses risk of mutation due to residual radiation from the Fukushima nuclear disaster

2023-04-07

Ionizing radiation from nuclear disasters are known to be harmful to the natural environment. The Fukushima Dai-ichi Nuclear Power Plant meltdown that occurred in 2011 is a prominent example of such a disaster in recent memory. Even a decade after the incident, concerns remain about the long-term effects of the radiation. In particular, it is not clear how the residual low-dose radiation might affect living organisms at the genetic level. The brunt of the disaster is usually borne by the floras inhabiting the contaminated areas since they cannot move. This, however, makes them ideal for ...

Simple but revolutionary modular organoids

2023-04-07

A team led by Masaya Hagiwara of RIKEN national science institute in Japan has developed an ingenious device, using layers of hydrogels in a cube-like structure, that allows researchers to construct complex 3D organoids without using elaborate techniques. The group also recently demonstrated the ability to use the device to build organoids that faithfully reproduce the asymmetric genetic expression that characterizes the actual development of organisms. The device has the potential to revolutionize the way we test drugs, and could also provide insights into how tissues develop and lead to ...

Efficacy, safety of anakinra plus standard of care for patients with severe COVID-19

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: